PT - JOURNAL ARTICLE AU - Adibi, Peyman AU - Ghassemian, Rezvan AU - Alavian, Seyed-Moayed AU - Ranjbar, Mitra AU - Mohammadalizadeh, Amir H. AU - Nematizadeh, Fariborz AU - Mamani, Mojgan AU - Rezazadeh, Mahdi AU - Keramat, Fariba AU - Ardalan, Ali AU - Esmaeili, Abbas AU - Zali, Mohammad R. TI - Effectiveness of Hepatitis B vaccination in children of chronic hepatitis B mothers DP - 2004 Oct 01 TA - Saudi Medical Journal PG - 1414--1418 VI - 25 IP - 10 4099 - http://smj.org.sa/content/25/10/1414.short 4100 - http://smj.org.sa/content/25/10/1414.full SO - Saudi Med J2004 Oct 01; 25 AB - OBJECTIVE: Although all newborns in Iran have been vaccinated against hepatitis B since March 1993, routine screening of pregnant women has not been conducted in prenatal care programs, yet transmission of hepatitis B via the maternal-fetal route is still a viable likelihood, which must be entertained.METHODS: The subjects were divided into 2 groups. The exposed group comprised 97 vaccinated children whose mothers were seropositive for hepatitis B surface antigen (HBsAg) and had not received hepatitis immunoglobulin at birth. The unexposed group consisted of 87 vaccinated children whose mothers were seronegative for hepatitis B surface antigen. We compared these 2 groups to determine the efficacy of vaccine alone in high-risk children. This study was conducted in Tehran, Iran, from June 2002 to December 2002. All children were born after 1993.RESULTS: Chronic infection (HBsAg positivity) was detected in 14.3% of children in the exposed group. There were no instances of chronic infection in the unexposed group (relative risk [RR]=13.48, 95% confidence intervals [CI] 1.8-100.02). Previous infection of hepatitis B (HBcAb positivity) was found in 29 (29.9%) children in the exposed group, but only one (1.2%) in the unexposed group (RR=26.01, 95% CI: 3.61-186.95). Immunity (HBsAb positivity) in the exposed group measured 48 (49.5%) and unexposed group measured 56 (64.4%) (R.R=0.76, 95% CI: 0.59-0.99).CONCLUSION: Vaccination alone did not induce immunity against hepatitis B in high-risk children; it seems that routine screening of pregnant women is necessary for determining whether neonates need hepatitis B immunoglobulin after birth.